<SEC-DOCUMENT>0001493152-26-013574-index.html : 20260330
<SEC-HEADER>0001493152-26-013574.hdr.sgml : 20260330
<ACCEPTANCE-DATETIME>20260330172910
ACCESSION NUMBER:		0001493152-26-013574
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260326
FILED AS OF DATE:		20260330
DATE AS OF CHANGE:		20260330

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			James Andrea S.
		CENTRAL INDEX KEY:			0002027010
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37648
		FILM NUMBER:		26812973

	MAIL ADDRESS:	
		STREET 1:		C/O ONCOCYTE CORPORATION
		STREET 2:		15 CUSHING
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Insight Molecular Diagnostics Inc.
		CENTRAL INDEX KEY:			0001642380
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				271041563
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2 INTERNATIONAL PLAZA DR., SUITE 510
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37217
		BUSINESS PHONE:		949-409-7600

	MAIL ADDRESS:	
		STREET 1:		2 INTERNATIONAL PLAZA DR., SUITE 510
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37217

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oncocyte Corp
		DATE OF NAME CHANGE:	20210920

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OncoCyte Corp
		DATE OF NAME CHANGE:	20200213

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Oncocyte Corp
		DATE OF NAME CHANGE:	20200205
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>